levofloxacin has been researched along with aspartic acid in 4 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (aspartic acid) | Trials (aspartic acid) | Recent Studies (post-2010) (aspartic acid) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 23,005 | 417 | 4,018 |
| Protein | Taxonomy | levofloxacin (IC50) | aspartic acid (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.638 | |
| Excitatory amino acid transporter 1 | Homo sapiens (human) | 90.1265 | |
| Excitatory amino acid transporter 2 | Homo sapiens (human) | 11 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 1.638 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Alonso, R; Cisterna, R; Mateo, E | 1 |
| Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, DH; Lee, JW; Lee, SM; Nam, RH; Park, JY | 1 |
| Han, H; Li, FX; Qin, XH; Wang, XL; Wu, DQ; Yu, JY; Zhang, FF; Zhu, J | 1 |
4 other study(ies) available for levofloxacin and aspartic acid
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Detection of parC mutations in Streptococcus pneumoniae by Real-time PCR and Taqman-MGB probes.
Topics: Anti-Infective Agents; Aspartic Acid; Codon; DNA Mutational Analysis; DNA Topoisomerase IV; Drug Resistance, Bacterial; Levofloxacin; Mutation; Ofloxacin; Oligonucleotide Probes; Pneumococcal Infections; Polymerase Chain Reaction; Serine; Streptococcus pneumoniae; Taq Polymerase | 2007 |
High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Asparagine; Aspartic Acid; DNA Gyrase; Female; Fluoroquinolones; Gene Expression; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Point Mutation; Treatment Outcome | 2015 |
Hydrophilic and degradable polyesters based on l-aspartic acid with antibacterial properties for potential application in hernia repair.
Topics: Animals; Anti-Bacterial Agents; Aspartic Acid; Cell Line; Disease Models, Animal; Escherichia coli; Herniorrhaphy; Hydrophobic and Hydrophilic Interactions; Levofloxacin; Mice; Polyesters; Staphylococcus aureus; Wound Healing | 2019 |